Jesus B Mantas - Net Worth and Insider Trading
Jesus B Mantas Net Worth
The estimated net worth of Jesus B Mantas is at least $809,708 dollars as of 2023-03-30. Jesus B Mantas is the Director of Biogen Inc and owns about 2,943 shares of Biogen Inc (BIIB) stock worth over $809,708. Details can be seen in Jesus B Mantas's Latest Holdings Summary section.
Transaction Summary of Jesus B Mantas
Jesus B Mantas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jesus B Mantas owns 1 companies in total, including Biogen Inc (BIIB) .
Click here to see the complete history of Jesus B Mantas’s form 4 insider trades.
Insider Ownership Summary of Jesus B Mantas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIIB | Biogen Inc | 2019-06-19 | director |
Jesus B Mantas Latest Holdings Summary
Jesus B Mantas currently owns a total of 1 stock. Jesus B Mantas owns 2,943 shares of Biogen Inc (BIIB) as of February 9, 2021, with a value of $809,708.
Latest Holdings of Jesus B Mantas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIIB | Biogen Inc | 2021-02-09 | 2,943 | 275.13 | 809,708 |
Holding Weightings of Jesus B Mantas
Jesus B Mantas Form 4 Trading Tracker
According to the SEC Form 4 filings, Jesus B Mantas has made a total of 1 transactions in Biogen Inc (BIIB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biogen Inc is the acquisition of 898 shares on February 9, 2021, which cost Jesus B Mantas around $239,766.
Insider Trading History of Jesus B Mantas
- 1
Jesus B Mantas Trading Performance
GuruFocus tracks the stock performance after each of Jesus B Mantas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jesus B Mantas is 1.76%. GuruFocus also compares Jesus B Mantas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jesus B Mantas within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jesus B Mantas's insider trading performs compared to the benchmark.
Performance of Jesus B Mantas
Average Relative Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | -1.05 | 1.76 | 26.32 | -15.78 | 3.23 | |
| Relative Return to S&P 500(%) | -0.13 | -6.46 | 13 | -33.06 | 1.08 |
Jesus B Mantas Ownership Network
Ownership Network List of Jesus B Mantas
Ownership Network Relation of Jesus B Mantas
Jesus B Mantas Owned Company Details
What does Biogen Inc do?
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.
Who are the key executives at Biogen Inc?
Jesus B Mantas is the director of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Jesus B Mantas made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .
In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Jesus B Mantas Mailing Address
Above is the net worth, insider trading, and ownership report for Jesus B Mantas. You might contact Jesus B Mantas via mailing address: Biogen Inc., 225 Binney Street, Cambridge Ma 02142.
